STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017

MONROVIA, Calif., Nov. 15, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will provide a webcast of President & CEO Caren Mason's presentation during its upcoming Investor and Analyst Day.

STAAR Surgical will host an Investor and Analyst Day on Thursday, November 16, 2017 at the STAAR Surgical R&D Center. Attendance is by invitation only. The Company will also provide a webcast beginning at 11 a.m. ET. A link to the webcast will be available on the "Events" section of the "Investors" page of STAAR Surgical's website at www.staar.com

An archived on-demand replay of the webcast presentation will also be available on STAAR Surgical's website approximately three hours after the conclusion of the live webcast. 

About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or "ICL".  More than 700,000 Visian ICLs have been implanted to date.  To learn more about the ICL go to: www.discovericl.com.  STAAR has approximately 340 full-time equivalent employees and markets lenses in over 60 countries.  Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com.

SOURCE STAAR Surgical Company